{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:56Z","timestamp":1790484356994,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40620-017-0406-x","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T02:02:28Z","timestamp":1496282548000},"page":"623-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Uremic Toxicity and Bone in CKD"],"prefix":"10.1093","volume":"30","author":[{"given":"Suguru","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-2339","authenticated-orcid":false,"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"issue":"Suppl","key":"406_CR1","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1046\/j.1440-1797.8.s.7.x","volume":"8","author":"M Fukagawa","year":"2003","unstructured":"Fukagawa M, Iwasaki Y, Kazama JJ (2003) Skeletal resistance to parathyroid hormone as a background abnormality in uremia. Nephrology (Carlton). 8(Suppl):S50\u2013S52","journal-title":"Nephrology (Carlton)"},{"issue":"102","key":"406_CR2","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/sj.ki.5001600","volume":"70","author":"Y Iwasaki","year":"2006","unstructured":"Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A et al. (2006) Insufficiency of PTH action on bone in uremia. Kidney Int Suppl. 70(102):S34\u2013S36. doi:\n10.1038\/sj.ki.5001600","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"406_CR3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","volume":"46","author":"J Bover","year":"1994","unstructured":"Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ (1994) The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Kidney Int 46(2):310\u2013317","journal-title":"Kidney Int"},{"issue":"3","key":"406_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5935\/0101-2800.20140042","volume":"36","author":"FC Barreto","year":"2014","unstructured":"Barreto FC, Barreto DV, Canziani ME, Tomiyama C, Higa A, Mozar A et al (2014) Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients. J Bras Nefrol 36(3):289\u2013296","journal-title":"J Bras Nefrol"},{"issue":"2","key":"406_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Drueke","year":"2016","unstructured":"Drueke TB, Massy ZA (2016) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89(2):289\u2013302. doi:\n10.1016\/j.kint.2015.12.004","journal-title":"Kidney Int"},{"issue":"2","key":"406_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19(2):179\u2013192. doi:\n10.1038\/nm.3074","journal-title":"Nat Med"},{"issue":"2","key":"406_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88(2):235\u2013240. doi:\n10.1038\/ki.2015.156","journal-title":"Kidney Int"},{"key":"406_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz C, Juppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91\u2013104. doi:\n10.1146\/annurev.med.051308.111339","journal-title":"Annu Rev Med"},{"issue":"1","key":"406_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"Carrillo-Lopez N, Panizo S, Alonso-Montes C, Roman-Garcia P, Rodriguez I, Martinez-Salgado C et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90(1):77\u201389. doi:\n10.1016\/j.kint.2016.01.024","journal-title":"Kidney Int"},{"issue":"10","key":"406_CR10","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M et al (2009) Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4(10):1551\u20131558. doi:\n10.2215\/CJN.03980609","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"406_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","volume":"69","author":"B Bammens","year":"2006","unstructured":"Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y (2006) Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69(6):1081\u20131087. doi:\n10.1038\/sj.ki.5000115","journal-title":"Kidney Int"},{"issue":"7","key":"406_CR12","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2014010042","volume":"26","author":"G Schulman","year":"2015","unstructured":"Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K et al (2015) Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol 26(7):1732\u20131746. doi:\n10.1681\/ASN.2014010042","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"406_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12882-016-0357-9","volume":"17","author":"G Schulman","year":"2016","unstructured":"Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M et al (2016) The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials. BMC Nephrol 17(1):141. doi:\n10.1186\/s12882-016-0357-9","journal-title":"BMC Nephrol"},{"issue":"3","key":"406_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","volume":"54","author":"T Akizawa","year":"2009","unstructured":"Akizawa T, Asano Y, Morita S, Wakita T, Onishi Y, Fukuhara S et al (2009) Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis 54(3):459\u2013467. doi:\n10.1053\/j.ajkd.2009.05.011","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"406_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.7150\/ijbs.15195","volume":"12","author":"J Chen","year":"2016","unstructured":"Chen J, Zhang X, Zhang H, Liu T, Zhang H, Teng J et al (2016) Indoxyl Sulfate Enhance the hypermethylation of Klotho and promote the process of vascular calcification in chronic kidney disease. Int J Biol Sci 12(10):1236\u20131246. doi:\n10.7150\/ijbs.15195","journal-title":"Int J Biol Sci"},{"issue":"1","key":"406_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40620-015-0260-7","volume":"30","author":"MJ Peeters","year":"2017","unstructured":"Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG et al (2017) Abdominal aortic calcification in patients with CKD. J Nephrol 30(1):109\u2013118. doi:\n10.1007\/s40620-015-0260-7","journal-title":"J Nephrol"},{"key":"406_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","volume":"113","author":"Kidney Disease","year":"2009","unstructured":"Kidney Disease (2009) Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD\u2013MBD). Kidney Int Suppl. 113:S1\u2013130. doi:\n10.1038\/ki.2009.188","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"406_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17(3):247\u2013288. doi:\n10.1111\/1744-9987.12058","journal-title":"Ther Apher Dial"},{"issue":"4","key":"406_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A et al (2016) diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67(4):559\u2013566. doi:\n10.1053\/j.ajkd.2015.06.023","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"406_CR20","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","volume":"20","author":"Y Iwasaki-Ishizuka","year":"2005","unstructured":"Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M (2005) Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 20(9):1904\u20131911. doi:\n10.1093\/ndt\/gfh876","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"406_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","volume":"45","author":"P Urena","year":"1994","unstructured":"Urena P, Kubrusly M, Mannstadt M, Hruby M, Trinh MM, Silve C et al (1994) The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45(2):605\u2013611","journal-title":"Kidney Int"},{"issue":"10","key":"406_CR22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/oxfordjournals.ndt.a027089","volume":"11","author":"P Urena","year":"1996","unstructured":"Urena P, Ferreira A, Morieux C, Drueke T, de Vernejoul MC (1996) PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 11(10):2008\u20132016","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"406_CR23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/ki.1995.248","volume":"47","author":"P Urena","year":"1995","unstructured":"Urena P, Mannstadt M, Hruby M, Ferreira A, Schmitt F, Silve C et al (1995) Parathyroidectomy does not prevent the renal PTH\/PTHrP receptor down-regulation in uremic rats. Kidney Int 47(6):1797\u20131805","journal-title":"Kidney Int"},{"issue":"6","key":"406_CR24","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Urena Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184\u20131190. doi:\n10.1016\/j.kint.2016.06.041","journal-title":"Kidney Int"},{"issue":"8","key":"406_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M et al (2007) Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71(8):738\u2013743. doi:\n10.1038\/sj.ki.5002097","journal-title":"Kidney Int"},{"issue":"2","key":"406_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","volume":"56","author":"H Tanaka","year":"2013","unstructured":"Tanaka H, Iwasaki Y, Yamato H, Mori Y, Komaba H, Watanabe H et al (2013) p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone 56(2):347\u2013354. doi:\n10.1016\/j.bone.2013.07.002","journal-title":"Bone"},{"key":"406_CR27","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.1038\/srep14381","volume":"5","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kazama JJ, Omori K, Matsuo K, Takahashi Y, Kawamura K et al (2015) Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients. Sci Rep 5:14381. doi:\n10.1038\/srep14381","journal-title":"Sci Rep"},{"issue":"10","key":"406_CR28","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","volume":"21","author":"Y Iwasaki","year":"2006","unstructured":"Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A et al (2006) Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Nephrol Dial Transplant 21(10):2768\u20132774. doi:\n10.1093\/ndt\/gfl311","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"406_CR29","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17(11):3223\u20133232. doi:\n10.1681\/ASN.2005111194","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"406_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00774-012-0411-z","volume":"31","author":"M Wakasugi","year":"2013","unstructured":"Wakasugi M, Kazama JJ, Taniguchi M, Wada A, Iseki K, Tsubakihara Y et al (2013) Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab 31(3):315\u2013321. doi:\n10.1007\/s00774-012-0411-z","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"406_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ki.2013.279","volume":"85","author":"F Tentori","year":"2014","unstructured":"Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG et al (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85(1):166\u2013173. doi:\n10.1038\/ki.2013.279","journal-title":"Kidney Int"},{"issue":"2","key":"406_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.ajkd.2014.05.024","volume":"65","author":"LA Bach","year":"2015","unstructured":"Bach LA, Hale LJ (2015) Insulin-like growth factors and kidney disease. Am J Kidney Dis 65(2):327\u2013336. doi:\n10.1053\/j.ajkd.2014.05.024","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"406_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00223-016-0152-4","volume":"99","author":"H Lundin","year":"2016","unstructured":"Lundin H, Saaf M, Strender LE, Nyren S, Johansson SE, Salminen H (2016) High serum insulin-like growth factor-binding protein 1 (IGFBP-1) is associated with high fracture risk independent of insulin-like growth factor 1 (IGF-I). Calcif Tissue Int 99(4):333\u2013339. doi:\n10.1007\/s00223-016-0152-4","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"406_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56(3):1084\u20131093. doi:\n10.1046\/j.1523-1755.1999.00617.x","journal-title":"Kidney Int"},{"issue":"2","key":"406_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","volume":"26","author":"RC Bucur","year":"2015","unstructured":"Bucur RC, Panjwani DD, Turner L, Rader T, West SL, Jamal SA (2015) Low bone mineral density and fractures in stages 3\u20135 CKD: an updated systematic review and meta-analysis. Osteoporos Int 26(2):449\u2013458. doi:\n10.1007\/s00198-014-2813-3","journal-title":"Osteoporos Int"},{"issue":"1","key":"406_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T et al (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study. Nephrol Dial Transplant 27(1):345\u2013351. doi:\n10.1093\/ndt\/gfr317","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"406_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2215\/CJN.04150609","volume":"5","author":"JJ Kazama","year":"2010","unstructured":"Kazama JJ, Koda R, Yamamoto S, Narita I, Gejyo F, Tokumoto A (2010) Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients. Clin J Am Soc Nephrol 5(2):292\u2013298. doi:\n10.2215\/CJN.04150609","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"406_CR38","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","volume":"48","author":"Y Iwasaki","year":"2011","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Fukagawa M (2011) Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease. Bone 48(6):1260\u20131267. doi:\n10.1016\/j.bone.2011.03.672","journal-title":"Bone"},{"key":"406_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bone.2015.07.015","volume":"81","author":"Y Iwasaki","year":"2015","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Matsugaki A, Nakano T, Fukagawa M (2015) Altered material properties are responsible for bone fragility in rats with chronic kidney injury. Bone 81:247\u2013254. doi:\n10.1016\/j.bone.2015.07.015","journal-title":"Bone"},{"issue":"1","key":"406_CR40","doi-asserted-by":"publisher","first-page":"e0116468","DOI":"10.1371\/journal.pone.0116468","volume":"10","author":"D Lanza","year":"2015","unstructured":"Lanza D, Perna AF, Oliva A, Vanholder R, Pletinck A, Guastafierro S et al (2015) Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. PLoS One 10(1):e0116468. doi:\n10.1371\/journal.pone.0116468","journal-title":"PLoS One"},{"issue":"2","key":"406_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","volume":"57","author":"Y Iwasaki","year":"2013","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Shimoda H, Fukagawa M (2013) Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease. Bone 57(2):477\u2013483. doi:\n10.1016\/j.bone.2013.07.037","journal-title":"Bone"},{"issue":"5","key":"406_CR42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/kisup.2013.93","volume":"3","author":"JJ Kazama","year":"2013","unstructured":"Kazama JJ, Iwasaki Y, Fukagawa M. Uremic osteoporosis. Kidney Int Suppl (2011). 2013;3(5):446\u201350. doi:\n10.1038\/kisup.2013.93\n\n.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"406_CR43","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R et al (2015) Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26(6):1466\u20131475. doi:\n10.1681\/ASN.2014040414","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"406_CR44","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M et al (2015) Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One 10(4):e0122691. doi:\n10.1371\/journal.pone.0122691","journal-title":"PLoS One"},{"key":"406_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-016-1368-3","author":"JJ Kazama","year":"2016","unstructured":"Kazama JJ (2016) Chronic kidney disease and fragility fracture. Clin Exp Nephrol. doi:\n10.1007\/s10157-016-1368-3","journal-title":"Clin Exp Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-017-0406-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0406-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0406-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:48Z","timestamp":1777564608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/30\/5\/623\/8371212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1007\/s40620-017-0406-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}